After-Hours Stock Movers 09/21: (OCRX) (NVAX) (RHT) Higher; (MLHR) (JBL) (ALOG) Lower (more...)

September 21, 2016 5:41 PM EDT

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

Today's After-Hours Movers

Ocera Therapeutics, Inc. (NASDAQ: OCRX) 24.2% HIGHER; announced completion of enrollment in STOP-ALF, a Phase 2a clinical trial to evaluate the Safety and Tolerability of Ornithine Phenylacetate in patients with Acute Liver Failure. The study was conducted by the Acute Liver Failure Study Group, an NIH-sponsored network of university tertiary care liver transplant sites, with support and supply of study medication from Ocera.

Herman Miller (NASDAQ: MLHR) 11% LOWER; reported Q1 EPS of $0.60, $0.02 worse than the analyst estimate of $0.62. Revenue for the quarter came in at $598.6 million versus the consensus estimate of $614.2 million. GUIDANCE: Herman Miller sees Q2 2017 EPS of $0.52-$0.60, versus the consensus of $0.60. Herman Miller sees Q2 2017 revenue of $580-600 million, versus the consensus of $601.1 million.

Novavax (NASDAQ: NVAX) 10.8% HIGHER; Director, Gail Bourdreaux, bought 100,000 shares on 09/20 at $1.45, bringing her stake to 200,000 shares.

Red Hat (NYSE: RHT) 5.2% HIGHER; reported Q2 EPS of $0.55, $0.01 better than the analyst estimate of $0.54. Revenue for the quarter came in at $600 million versus the consensus estimate of $593.34 million. Red Hat sees Q3 2017 EPS of $0.34, versus the consensus of $0.57. Red Hat sees Q3 2017 revenue of $613-623 million, versus the consensus of $615.2 million. Red Hat sees FY2017 EPS of $2.23-$2.25, versus the consensus of $2.21. Red Hat sees FY2017 revenue of $2.415-2.435 billion, versus the consensus of $2.4 billion.

Jabil Circuit (NYSE: JBL) 4.6% LOWER; reported Q4 EPS of $0.28, $0.03 better than the analyst estimate of $0.25. Revenue for the quarter came in at $4.43 billion versus the consensus estimate of $4.27 billion. Jabil Circuit sees Q1 2017 EPS of $0.54-$0.74, versus the consensus of $0.60. Jabil Circuit sees Q1 2017 revenue of $4.8-5.0 billion, versus the consensus of $4.84 billion.

Analogic (NASDAQ: ALOG) 3.3% LOWER; reported Q4 EPS of $1.02, $0.15 worse than the analyst estimate of $1.17. Revenue for the quarter came in at $138 million versus the consensus estimate of $139.03 million.

Chesapeake Utilities Corporation (NYSE: CPK) 2% LOWER; announced the commencement of an underwritten public offering of its common stock, with an aggregate value not to exceed $52 million.

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) 0.7% HIGHER; announced that it is offering to sell, subject to market and other conditions, up to $225 million of its common stock in an underwritten public offering. Sarepta also intends to grant the underwriters a 30-day option to purchase from it up to an additional 15% of the shares of common stock offered in the public offering.

Bed Bath & Beyond (NASDAQ: BBBY) 1% HIGHER; reported Q2 EPS of $1.11, in-line with the analyst estimate of $1.16. Revenue for the quarter came in at $2.99 billion versus the consensus estimate of $3.05 billion. Comps fell 1.2 percent versus expectations of a 0.4 percent gain. GUIDANCE: Bed Bath & Beyond sees FY2016 EPS of $4.50-$5.00, versus the consensus of $4.83. For earnings history and earnings-related data on Bed Bath & Beyond (BBBY) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Special Reports

Related Entities

After-Hours Movers, Earnings

Add Your Comment